A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer
Public ClinicalTrials.gov record NCT05169684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-label, Randomized Controlled Trial of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety, efficacy, tolerability, and toxicity of docetaxel alone, in combination with BMS-986218, or in combination with nivolumab plus BMS-986218 in men who have metastatic castration-resistant prostate cancer (mCRPC) that progressed after novel antiandrogen therapy and have not received chemotherapy for mCRPC.
Study identification
- NCT ID
- NCT05169684
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 14, 2022 (Actual)
- Primary completion
- Dec 6, 2023 (Actual)
- Completion
- Dec 6, 2023 (Actual)
- Last update posted
- Jun 10, 2025
2022 – 2023
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology - Tucson - Wilmot Road Location | Tucson | Arizona | 85711-2701 | — |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles | California | 90027-5969 | — |
| Rocky Mountain Cancer Centers - Littleton | Littleton | Colorado | 80120-4413 | — |
| Yale School Of Medicine | New Haven | Connecticut | 06510-3206 | — |
| Medical Oncology Hematology Consultants - Newark | Newark | Delaware | 19713-2055 | — |
| The Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322-1013 | — |
| Local Institution - 0004 | Marietta | Georgia | 30060 | — |
| The University of Chicago Medical Center - Duchossois Center for Advanced Medicine | Chicago | Illinois | 60637-1426 | — |
| University Of Iowa Hospitals And Clinics | Iowa City | Iowa | 52242 | — |
| The Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110-1010 | — |
| Local Institution - 0006 | New York | New York | 10032-3729 | — |
| Duke Cancer Institute | Durham | North Carolina | 27710 | — |
| Oncology Hematology Care, Inc. - Eastgate | Cincinnati | Ohio | 45245-1995 | — |
| Willamette Valley Cancer Institute | Eugene | Oregon | 97477 | — |
| Texas Oncology-Beaumont Mamie McFaddin Ward Cancer Center | Beaumont | Texas | 77702 | — |
| Texas Oncology | Bedford | Texas | 76022-6920 | — |
| Texas Oncology - Denton North | Denton | Texas | 76201-4315 | — |
| Texas Oncology | Flower Mound | Texas | 75028 | — |
| Texas Oncology - Fort Worth Cancer Center | Fort Worth | Texas | 76104-2150 | — |
| The University of Texas - MD Anderson Cancer Center - Genitourinary (GU) Cancer Center | Houston | Texas | 77030-4004 | — |
| Texas Oncology - McKinney | McKinney | Texas | 75071-8106 | — |
| Texas Oncology- Tyler | Tyler | Texas | 75702-8363 | — |
| Local Institution - 0056 | Hampton | Virginia | 23666-5963 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05169684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 10, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05169684 live on ClinicalTrials.gov.